Insider Transactions Reported by 21 Insiders of Esperion Therapeutics, Inc.

Symbol
ESPR on Nasdaq
Location
Ann Arbor, MI

Insiders trading volume in the past year

Esperion Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BIOTECH TARGET N V 10%+ Owner $5,575,065 24 May 2021
Sheldon L. Koenig President and CEO, Director $5,401,466 -$309,873 -5.4% 17 Dec 2025
Benjamin Halladay Chief Financial Officer $1,714,414 -$60,321 -3.4% 17 Dec 2025
Benjamin Looker General Counsel $1,415,113 -$53,614 -3.7% 17 Dec 2025
John B. Harlow Jr. Chief Commercial Officer $1,316,061 04 Dec 2025
Joanne M. Foody Chief Medical Officer $709,168 17 Jul 2024
Eric Warren Chief Commercial Officer $362,073 -$4,448 -1.2% 17 Apr 2025
Alan Fuhrman Director $132,602 23 May 2024
GOTTO ANTONIO M JR MD D PHIL Director $128,120 23 May 2024
Richard Bartram Chief Financial Officer $103,025 14 Mar 2022
J. MARTIN CARROLL Director $78,120 29 May 2025
Jay Shepard Director $67,679 29 May 2025
DANIEL JANNEY Director $59,777 27 May 2021
STEPHEN ROCAMBOLI Director $55,408 29 May 2025
H. Fischer Seth Director $48,920 29 May 2025
MARK E. MCGOVERN Director $35,419 27 May 2021
Robert E. Hoffman Director $4,224 29 May 2025
Jeffrey Berkowitz Director 26 May 2022
NICOLE VITULLO Director 29 May 2025
JOHN CRAIG THOMPSON Director 01 Jul 2025
Tracy M. Woody Director 29 May 2025

Recent Insider Transactions by Companies or Individuals for Esperion Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.